Teknologi Kesehatan
Perusahaan Italia yang terlibat dalam satu sektor: teknologi kesehatan
Perusahaan Italia ini beroperasi di sektor yang sama, teknologi kesehatan. Masing-masing mencakup statistik utama seperti harga saham, perubahan harian, dan volume perdagangan untuk membantu anda membuat keputusan trading yang lebih tepat. Baik anda ingin melacak raksasa industri seperti Eli Lilly and Company atau mengamati pergerakan dengan volume tinggi seperti Safilo Group S.p.A., daftar ini menawarkan wawasan berharga untuk strategi trading apa pun. Saring dan bandingkan perusahaan dan ikuti tren pasar dengan mudah.
Simbol | Kap pasar | Harga | Perubahan % | Vol | Volume relatif | P/E | EPS terdilusi TTM | Pertumbuhan EPS terdilusi TTM YoY | Imbal hasil dividen % TTM | Penilaian analis |
|---|---|---|---|---|---|---|---|---|---|---|
 4LLYEli Lilly and Company | 934,41 B EUR | 1.003,6 EUR | +0,48% | 0 | 0,00 | 41,74 | 24,05 EUR | +115,50% | 0,56% | Pembelian |
| 1LLYEli Lilly and Company | 934,41 B EUR | 1.003,2 EUR | +0,37% | 463 | 0,72 | 41,72 | 24,05 EUR | +115,50% | 0,56% | Pembelian |
 4JNJJohnson & Johnson | 494,52 B EUR | 207,40 EUR | +2,07% | 4 | — | 27,71 | 7,49 EUR | −9,98% | 2,21% | Pembelian |
| 1JNJJohnson & Johnson | 494,52 B EUR | 207,35 EUR | +2,07% | 175 | 1,08 | 27,70 | 7,49 EUR | −9,98% | 2,21% | Pembelian |
 4ABBVAbbVie, Inc. | 345,22 B EUR | 196,30 EUR | +0,31% | 0 | — | 111,86 | 1,75 EUR | −19,05% | 2,99% | Pembelian |
| 1ABBVAbbVie, Inc. | 345,22 B EUR | 196,30 EUR | +0,31% | 35 | 1,52 | 111,86 | 1,75 EUR | −19,05% | 2,99% | Pembelian |
| 11ROGRoche Holding Ltd | 275,87 B EUR | 349,05 EUR | −0,40% | 32 | 1,52 | 20,26 | 17,23 EUR | +56,93% | 3,07% | Pembelian |
 1RORoche Holding Ltd | 275,87 B EUR | 358,4 EUR | +1,41% | 4 | 0,16 | 20,81 | 17,23 EUR | +56,93% | 3,33% | Pembelian |
 4MRKXMerck & Co., Inc. | 256,05 B EUR | 102,60 EUR | −0,79% | 0 | 0,00 | 33,36 | 3,08 EUR | −51,56% | 2,78% | Pembelian |
| 1MRKXMerck & Co., Inc. | 256,05 B EUR | 102,64 EUR | −0,72% | 417 | 4,36 | 33,37 | 3,08 EUR | −51,56% | 2,78% | Pembelian |
 1NOVNNovartis AG | 234,52 B EUR | 129,04 EUR | +0,30% | 1,09 K | 0,52 | 21,22 | 6,08 EUR | +2,70% | 3,13% | Netral |
 1AMGNAmgen Inc. | 161,2 B EUR | 300,55 EUR | +0,52% | 67 | 1,94 | 24,15 | 12,45 EUR | +22,91% | 2,84% | Pembelian |
| 4AMGNAmgen Inc. | 161,2 B EUR | 300,60 EUR | +0,48% | 0 | — | 24,15 | 12,45 EUR | +22,91% | 2,84% | Pembelian |
 4TMOThermo Fisher Scientific Inc. | 159,15 B EUR | 422,9 EUR | +1,32% | 0 | — | 26,86 | 15,74 EUR | −0,06% | 0,36% | Pembelian kuat |
| 1TMOThermo Fisher Scientific Inc. | 159,15 B EUR | 422,8 EUR | +1,27% | 5 | 0,17 | 26,86 | 15,74 EUR | −0,06% | 0,36% | Pembelian kuat |
 1ABTAbbott Laboratories | 137,77 B EUR | 78,18 EUR | −1,56% | 85 | 0,48 | 25,16 | 3,11 EUR | −56,40% | 2,67% | Pembelian |
 4GILDGilead Sciences, Inc. | 135,06 B EUR | 106,24 EUR | −1,72% | 0 | — | 16,70 | 6,36 EUR | +44,70% | 2,54% | Pembelian |
| 1GILDGilead Sciences, Inc. | 135,06 B EUR | 106,28 EUR | −1,59% | 302 | 2,46 | 16,71 | 6,36 EUR | +44,70% | 2,54% | Pembelian |
 4ISRGIntuitive Surgical, Inc. | 130,97 B EUR | 363,15 EUR | −1,64% | 0 | 0,00 | 50,90 | 7,14 EUR | +13,23% | 0,00% | Pembelian |
| 1ISRGIntuitive Surgical, Inc. | 130,97 B EUR | 363,25 EUR | −1,60% | 36 | 0,56 | 50,91 | 7,14 EUR | +13,23% | 0,00% | Pembelian |
 4PFEPfizer Inc. | 126,97 B EUR | 22,270 EUR | +0,32% | 443 | 6,48 | 19,73 | 1,13 EUR | −11,40% | 6,69% | Pembelian |
| 1PFEPfizer Inc. | 126,97 B EUR | 22,280 EUR | +0,32% | 1,68 K | 0,42 | 19,74 | 1,13 EUR | −11,40% | 6,69% | Pembelian |
 4DHRDanaher Corporation | 115,59 B EUR | 161,1 EUR | −0,34% | 0 | — | 35,97 | 4,48 EUR | −6,07% | 0,72% | Pembelian kuat |
| 1DHRDanaher Corporation | 115,59 B EUR | 161,20 EUR | −0,31% | 0 | 0,00 | 35,99 | 4,48 EUR | −6,07% | 0,72% | Pembelian kuat |
 4SYKStryker Corporation | 104,35 B EUR | 269,4 EUR | +0,37% | 0 | — | 36,05 | 7,47 EUR | +9,09% | 1,10% | Pembelian |
| 1SYKStryker Corporation | 104,35 B EUR | 269,3 EUR | +0,34% | 0 | 0,00 | 36,04 | 7,47 EUR | +9,09% | 1,10% | Pembelian |
 4BMYBristol-Myers Squibb Company | 99,97 B EUR | 48,76 EUR | +0,49% | 0 | — | 15,81 | 3,08 EUR | +25,24% | 4,43% | Pembelian |
| 1BMYBristol-Myers Squibb Company | 99,97 B EUR | 48,615 EUR | +0,58% | 585 | 16,03 | 15,77 | 3,08 EUR | +25,24% | 4,43% | Pembelian |
 1VRTXVertex Pharmaceuticals Incorporated | 98,07 B EUR | 381,45 EUR | −0,40% | 0 | 0,00 | 26,13 | 14,60 EUR | — | 0,00% | Pembelian |
| 4VRTXVertex Pharmaceuticals Incorporated | 98,07 B EUR | 381,55 EUR | −0,74% | 0 | — | 26,13 | 14,60 EUR | — | 0,00% | Pembelian |
 1SANSanofi SA | 92,9 B EUR | 76,38 EUR | −0,81% | 2,48 K | 1,39 | 17,95 | 4,26 EUR | −3,87% | 5,35% | Pembelian |
| 4SANSanofi SA | 92,9 B EUR | 76,38 EUR | −0,52% | 0 | 0,00 | 17,95 | 4,26 EUR | −3,87% | 5,35% | Pembelian |
 4MDTMedtronic Plc | 91,23 B EUR | 70,34 EUR | −0,85% | 0 | 0,00 | 22,17 | 3,17 EUR | −0,69% | 3,46% | Pembelian |
| 1MDTMedtronic Plc | 91,23 B EUR | 70,36 EUR | −0,79% | 70 | 0,23 | 22,18 | 3,17 EUR | −0,69% | 3,46% | Pembelian |
 1ELEssilorLuxottica SA | 83,21 B EUR | 177,75 EUR | −1,25% | 7,76 K | 0,81 | 35,68 | 4,98 EUR | −2,85% | 2,23% | Pembelian kuat |
| 4ELEssilorLuxottica SA | 83,21 B EUR | 178,40 EUR | −0,36% | 10 | 0,67 | 35,81 | 4,98 EUR | −2,85% | 2,23% | Pembelian kuat |
 1BSXBoston Scientific Corporation | 63,08 B EUR | 41,830 EUR | −1,39% | 0 | 0,00 | 20,27 | 2,06 EUR | +63,62% | 0,00% | Pembelian kuat |
| 4BSXBoston Scientific Corporation | 63,08 B EUR | 41,84 EUR | −1,33% | 0 | — | 20,27 | 2,06 EUR | +63,62% | 0,00% | Pembelian kuat |
 4MRKMerck KGaA | 60,06 B EUR | 137,30 EUR | −0,58% | 0 | — | 23,58 | 5,82 EUR | −10,15% | 1,59% | Pembelian |
| 1MRKMerck KGaA | 60,06 B EUR | 137,25 EUR | −0,58% | 0 | 0,00 | 23,57 | 5,82 EUR | −10,15% | 1,59% | Pembelian |
 4REGNRegeneron Pharmaceuticals, Inc. | 56 B EUR | 528,9 EUR | −0,47% | 0 | — | 14,89 | 35,52 EUR | −2,18% | 0,59% | Pembelian |
| 1REGNRegeneron Pharmaceuticals, Inc. | 56 B EUR | 528,7 EUR | −0,09% | 0 | 0,00 | 14,88 | 35,52 EUR | −2,18% | 0,59% | Pembelian |
 4UCBUCB S.A. | 49,84 B EUR | 264,5 EUR | +0,57% | 0 | — | 32,97 | 8,02 EUR | +46,56% | 0,39% | Pembelian kuat |
 4EWEdwards Lifesciences Corporation | 43,69 B EUR | 74,86 EUR | −0,24% | 0 | — | 46,99 | 1,59 EUR | +15,15% | 0,00% | Pembelian |
| 1EWEdwards Lifesciences Corporation | 43,69 B EUR | 74,96 EUR | −0,11% | 0 | 0,00 | 47,05 | 1,59 EUR | +15,15% | 0,00% | Pembelian |
 1GALDGalderma Group AG | 42,17 B EUR | 187 EUR | +2,19% | 0 | 0,00 | 82,15 | 2,28 EUR | +151,65% | 0,21% | Pembelian |
 1IDXXIDEXX Laboratories, Inc. | 39,58 B EUR | 492,2 EUR | −0,24% | 9 | — | 41,84 | 11,76 EUR | +17,59% | 0,00% | Pembelian |
 1SHLSiemens Healthineers AG | 39,15 B EUR | 35,18 EUR | +2,09% | 0 | 0,00 | 18,85 | 1,87 EUR | +0,45% | 2,85% | Pembelian |
| 4SHLSiemens Healthineers AG | 39,15 B EUR | 34,98 EUR | +0,37% | 0 | — | 18,74 | 1,87 EUR | +0,45% | 2,85% | Pembelian |
 1LONNLonza Group AG | 36,63 B EUR | 535,4 EUR | +2,76% | 0 | 0,00 | — | −4,22 EUR | −144,49% | 1,01% | Pembelian |
 1BDXBecton, Dickinson and Company | 36,31 B EUR | 130,60 EUR | +0,73% | 0 | 0,00 | 38,26 | 3,41 EUR | −29,53% | 2,75% | Pembelian |
| 4BDXBecton, Dickinson and Company | 36,31 B EUR | 130,10 EUR | +0,66% | 0 | — | 38,11 | 3,41 EUR | −29,53% | 2,75% | Pembelian |
 4BAYNBayer AG | 34,87 B EUR | 35,43 EUR | −0,28% | 0 | 0,00 | — | −2,19 EUR | +33,72% | 0,31% | Pembelian |
| 1BAYNBayer AG | 34,87 B EUR | 35,38 EUR | −0,39% | 13,79 K | 0,24 | — | −2,19 EUR | +33,72% | 0,31% | Pembelian |
 1ALNYAlnylam Pharmaceuticals, Inc | 34,45 B EUR | 256,7 EUR | −0,08% | 0 | 0,00 | 70,47 | 3,64 EUR | — | 0,00% | Pembelian |
 1AAgilent Technologies, Inc. | 33,17 B EUR | 115,95 EUR | −1,28% | 10 | 0,58 | 27,32 | 4,24 EUR | +18,55% | 0,74% | Pembelian |
| 4AAgilent Technologies, Inc. | 33,17 B EUR | 115,95 EUR | −1,40% | 0 | — | 27,32 | 4,24 EUR | +18,55% | 0,74% | Pembelian |
 1WATWaters Corporation | 31,59 B EUR | 320,0 EUR | −0,68% | 0 | 0,00 | 47,06 | 6,80 EUR | −33,30% | 0,00% | Pembelian |
 1ZTSZoetis, Inc. Class A | 29,87 B EUR | 71,40 EUR | +1,45% | 535 | 2,34 | 13,67 | 5,22 EUR | +1,50% | 2,51% | Pembelian |
| 4ZTSZoetis, Inc. Class A | 29,87 B EUR | 71,50 EUR | +1,50% | 0 | — | 13,69 | 5,22 EUR | +1,50% | 2,51% | Pembelian |
 1ALCAlcon AG | 29,12 B EUR | 58,22 EUR | −0,07% | 3,73 K | 0,89 | 40,45 | 1,44 EUR | −30,93% | 0,52% | Pembelian kuat |
 1RVMDRevolution Medicines, Inc. | 27,56 B EUR | 122,80 EUR | −3,80% | 83 | 0,38 | — | −6,12 EUR | −65,67% | 0,00% | Pembelian kuat |
 1IQVIQVIA Holdings Inc | 26,94 B EUR | 160,30 EUR | −0,59% | 0 | 0,00 | 22,96 | 6,98 EUR | +2,95% | 0,00% | Pembelian kuat |
 1DXCMDexCom, Inc. | 26,15 B EUR | 66,2 EUR | −1,19% | 122 | 2,58 | 32,71 | 2,02 EUR | +64,35% | 0,00% | Pembelian kuat |
 1GEHCGE Healthcare Technologies Inc. | 26,03 B EUR | 56,69 EUR | −0,04% | 56 | 0,87 | 15,68 | 3,62 EUR | −17,76% | 0,21% | Pembelian |
 1BIIBBiogen Inc. | 25,48 B EUR | 172,46 EUR | +1,90% | 2 | 0,14 | 21,38 | 8,07 EUR | −13,83% | 0,00% | Pembelian |
| 4BIIBBiogen Inc. | 25,48 B EUR | 171,60 EUR | +1,43% | 0 | 0,00 | 21,28 | 8,07 EUR | −13,83% | 0,00% | Pembelian |
 1RMDResMed Inc. | 24,76 B EUR | 170,25 EUR | +0,56% | 0 | 0,00 | 18,96 | 8,98 EUR | +9,06% | 1,22% | Pembelian |
 1ILMNIllumina, Inc. | 20,99 B EUR | 143,66 EUR | +6,35% | 62 | 4,28 | 30,12 | 4,77 EUR | — | 0,00% | Pembelian |
| 4ILMNIllumina, Inc. | 20,99 B EUR | 143,60 EUR | +6,07% | 0 | — | 30,11 | 4,77 EUR | — | 0,00% | Pembelian |
 1WSTWest Pharmaceutical Services, Inc. | 20,49 B EUR | 286,7 EUR | +0,28% | 0 | 0,00 | 44,28 | 6,47 EUR | +9,99% | 0,26% | Pembelian kuat |
 1MTDMettler-Toledo International Inc. | 20,37 B EUR | 990 EUR | −0,45% | 0 | — | 26,83 | 36,91 EUR | −0,42% | 0,00% | Pembelian |
 1INSMInsmed Incorporated | 18,61 B EUR | 82,70 EUR | −1,42% | 198 | 55,00 | — | −4,97 EUR | +9,57% | 0,00% | Pembelian kuat |
 4INCYIncyte Corporation | 17,88 B EUR | 92,66 EUR | +4,14% | 0 | — | 15,14 | 6,12 EUR | +1.948,79% | 0,00% | Pembelian |
| 1INCYIncyte Corporation | 17,88 B EUR | 92,36 EUR | +3,85% | 0 | 0,00 | 15,09 | 6,12 EUR | +1.948,79% | 0,00% | Pembelian |
 4DIMSartorius Stedim Biotech SA | 17,3 B EUR | 179,4 EUR | +0,73% | 0 | — | 65,11 | 2,76 EUR | +31,23% | 0,39% | Pembelian kuat |
 1STMNStraumann Holding AG | 16,49 B EUR | 107 EUR | +4,90% | 0 | 0,00 | 44,69 | 2,39 EUR | −7,10% | 1,05% | Pembelian |
 4MRNAModerna, Inc. | 16,42 B EUR | 40,255 EUR | +1,00% | 0 | 0,00 | — | −7,05 EUR | +12,55% | 0,00% | Netral |
| 1MRNAModerna, Inc. | 16,42 B EUR | 40,270 EUR | +1,04% | 6,71 K | 0,74 | — | −7,05 EUR | +12,55% | 0,00% | Netral |
 4VTRSViatris, Inc. | 16,35 B EUR | 13,806 EUR | −0,26% | 0 | 0,00 | — | −0,22 EUR | +92,37% | 2,96% | Pembelian |
| 1VTRSViatris, Inc. | 16,35 B EUR | 13,814 EUR | −0,10% | 99 | 1,81 | — | −0,22 EUR | +92,37% | 2,96% | Pembelian |
 1ZBHZimmer Biomet Holdings, Inc. | 15,03 B EUR | 77,66 EUR | +1,70% | 0 | — | 23,30 | 3,33 EUR | −20,08% | 1,07% | Pembelian |
 1GHGuardant Health, Inc. | 14,96 B EUR | 114,30 EUR | +7,18% | 0 | 0,00 | — | −2,94 EUR | +5,77% | 0,00% | Pembelian kuat |
| 1SRTSartorius AG | 14,63 B EUR | 188,8 EUR | −0,42% | 0 | — | 80,12 | 2,36 EUR | +70,35% | 0,39% | Pembelian |
| 4SRT3Sartorius AG Pref | 14,63 B EUR | 238,00 EUR | −0,13% | 0 | — | 101,00 | 2,36 EUR | +70,35% | 0,31% | Pembelian |
| 4SRTSartorius AG | 14,63 B EUR | 187,8 EUR | 0,00% | 0 | 0,00 | 79,70 | 2,36 EUR | +70,35% | 0,39% | Pembelian |
 1NBIXNeurocrine Biosciences, Inc. | 14,4 B EUR | 143,55 EUR | +2,24% | 0 | 0,00 | 25,50 | 5,63 EUR | +106,52% | 0,00% | Pembelian kuat |
 1SOBISwedish Orphan Biovitrum AB | 13,69 B EUR | 40,30 EUR | −1,23% | 0 | — | 173,69 | 0,23 EUR | −77,84% | 0,00% | Pembelian |
 1SOONSonova Holding AG | 12,83 B EUR | 220,0 EUR | −1,57% | 0 | 0,00 | 28,13 | 7,82 EUR | −17,15% | 2,14% | Netral |
 1JAZZJazz Pharmaceuticals Public Limited Company | 12,48 B EUR | 199,5 EUR | −0,52% | 0 | 0,00 | — | −0,02 EUR | −100,23% | 0,00% | Pembelian |
 1COOCooper Companies, Inc. | 11,6 B EUR | 59,09 EUR | +1,62% | 0 | 0,00 | 58,55 | 1,01 EUR | −44,56% | 0,00% | Pembelian |
 1EXELExelixis, Inc. | 11,55 B EUR | 46,075 EUR | +2,21% | 0 | 0,00 | 17,64 | 2,61 EUR | +28,17% | 0,00% | Pembelian |
 1BBIOBridgeBio Pharma, Inc. | 11,49 B EUR | 58,99 EUR | +3,02% | 20 | 0,40 | — | −3,24 EUR | +0,66% | 0,00% | Pembelian kuat |
 1ALGNAlign Technology, Inc. | 11,06 B EUR | 153,35 EUR | +1,29% | 0 | 0,00 | 29,69 | 5,16 EUR | +1,67% | 0,00% | Pembelian |
 1AXSMAxsome Therapeutics, Inc. | 10,96 B EUR | 218,2 EUR | +5,31% | 86 | 3,76 | — | −3,24 EUR | +39,31% | 0,00% | Pembelian kuat |
 1IONSIonis Pharmaceuticals, Inc. | 10,68 B EUR | 63,56 EUR | −0,75% | 0 | 0,00 | — | −1,82 EUR | +34,02% | 0,00% | Pembelian kuat |
 RECRecordati S.p.A. | 10,51 B EUR | 50,85 EUR | −0,20% | 330,96 K | 0,62 | 22,55 | 2,26 EUR | +12,81% | 2,63% | Pembelian |
 4ORNBVOrion Oyj Class B | 9,81 B EUR | 68,90 EUR | −1,71% | 0 | — | 18,31 | 3,76 EUR | +52,14% | 2,47% | Pembelian |
| 1ORNBVOrion Oyj Class B | 9,81 B EUR | 68,35 EUR | −2,77% | 0 | 0,00 | 18,17 | 3,76 EUR | +52,14% | 2,47% | Pembelian |
 4BMRNBioMarin Pharmaceutical Inc. | 9,7 B EUR | 50,00 EUR | +1,19% | 0 | 0,00 | 42,15 | 1,19 EUR | −52,38% | 0,00% | Pembelian |